Brief: VIB And Surface Oncology Announce Publication In Cell Reports Revealing Il-27 Structure And The Mechanism Of Action For Srf388
Oct 19 (Reuters) - Surface Oncology Inc SURF.O :
* VIB AND SURFACE ONCOLOGY ANNOUNCE PUBLICATION IN CELL
REPORTS
REVEALING IL-27 STRUCTURE AND THE MECHANISM OF ACTION FOR SRF388
* SURFACE ONCOLOGY INC - FINDINGS SUPPORT ONGOING CLINICAL
INVESTIGATION OF SRF388
* SURFACE ONCOLOGY INC - STUDY ELUCIDATES HOW SRF388 BINDS
TO
IL-27 TO PREVENT INTERACTION WITH IL-27 RECEPTOR
Source text for Eikon: ID:nGNX1v09GD
Further company coverage: SURF.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on VIB Vermoegen AG
See all newsVIB Vermögen H1 rental income falls, guidance confirmed
Brief: VIB Vermogen H1 Revenues EUR 46.8 Million
Brief: Branicks Group AG - Initiates Control And Profit Transfer Agreement With VIB
Brief: VIB Vermogen H1 FFO EUR 47.8 Million
Brief: VIB Vermögen Says Takeover Of The Business With Institutional Investors Of Branicks Group AG, Settlement Of The Loan Due